Patents Assigned to DRK BLUTSPENDEDIENST BADEN-W?RTTEMBERG-HESSEN GMBH
  • Publication number: 20190350980
    Abstract: Described herein are methods of promoting engraftment of a cell transplant and methods of killing hematopoietic stem cells by administering a population of T cells, NK cells or cytotoxic immune effector cells comprising a cell-surface receptor for a stem cell-specific antigen. Also described herein is a composition comprising T cells, NK cells or cytotoxic immune effector cells genetically modified to encode a cell-surface receptor for a stem cell-specific antigen.
    Type: Application
    Filed: January 18, 2018
    Publication date: November 21, 2019
    Applicant: DRK BLUTSPENDEDIENST BADEN-W?RTTEMBERG-HESSEN GMBH
    Inventors: Thalia PAPAYANNOPOULOU, Halvard B. BONIG, Michael HUDECEK